Cagent Vascular
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease
$41MSeries D
Role not disclosedLoading investors…
Activity from announced rounds
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease
Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions
Provides AI-powered cloud cost governance and optimization for enterprises